Both in Pharmaceuticals
Zenas BioPharma vs Xeris Biopharma Holdings
Over the past year ZBIO returned +21.5% and XERS returned +17.4%; their daily moves had a correlation of 0.10.
ZBIO +21.5% XERS +17.4%Growth of $1, one year, split-adjusted
| Metric | ZBIO | XERS |
|---|---|---|
| Price | $26.97 | $9.56 |
| Market cap | $1.76B | $1.74B |
| Today | +0.78% | −4.21% |
| 1 month | −16.6% | +13.3% |
| 6 months | +38.0% | +64.8% |
| Year to date | −25.7% | +21.8% |
| 1 year | +31.1% | +18.3% |
| Revenue growth (YoY) | — | +28.7% |
| Gross margin | 100.0% | 86.4% |
| Net margin | −11145.6% | −33.8% |
| P/E (TTM) | — | — |
| Price / sales | 1,757.8× | 5.2× |
| Net cash | $346.1M | -$130.8M |
| Dividend yield | — | — |
| Volatility (60d) | 53.6% | 50.8% |
| Short % of float | 38.1% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).